Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Salzer

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Geburtshilfe Und Frauenheilkunde|March 1, 1987
[Therapeutic and prognostic results of a prospective multicenter ovarian cancer study of FIGO stages I and II]P Sevelda, E Gitsch, C Dittrich, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 14, 2015
Interobserver agreement and accuracy of non-invasive diagnosis of endometriosis by transvaginal sonographyA Tammaa, N Fritzer, P Lozano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 1992
Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancerP. Sevelda, N. Vavra, R. Fitz, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1992
[Prognostic factors of radically operated stage Ib cervix cancer]N Vavra, H Kucera, W Eppel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Clonogenic growth in vitro: an independent biologic prognostic factor in ovarian carcinomaC Dittrich, E Dittrich, P Sevelda, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|June 1, 1986
Studies on the effects of betamethasone, L-carnitine, and betamethasone-L-carnitine combinations on the dipalmitoyl phosphatidylcholine content and phosphatidylcholine species composition in foetal rat lungsA Lohninger, H P Krieglsteiner, H Salzer, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1997
[Guidelines for surgical treatment of cervix carcinoma developed by the Standard Committee of the Austrian Society of Gynecology and Obstetrics. Austrian Society of Gynecology and Obstetrics]R Winter, H Concin, L Fuith, et al.
International Journal of Oncology|October 17, 1998
Prediction of toxicity but not of clinical course by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatinA Obermair, P Speiser, M Thoma, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1991
[Ferritin level in newborn infants after prepartal iron medication]M Barrada, N Pateisky, C Schatten, et al.
Wiener Klinische Wochenschrift|May 24, 1985
[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval]C C Zielinski, R Kuzmits, E Kubista, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Geburtshilfe Und Frauenheilkunde|March 1, 1987
[Therapeutic and prognostic results of a prospective multicenter ovarian cancer study of FIGO stages I and II]P Sevelda, E Gitsch, C Dittrich, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 14, 2015
Interobserver agreement and accuracy of non-invasive diagnosis of endometriosis by transvaginal sonographyA Tammaa, N Fritzer, P Lozano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 1992
Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancerP. Sevelda, N. Vavra, R. Fitz, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1992
[Prognostic factors of radically operated stage Ib cervix cancer]N Vavra, H Kucera, W Eppel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Clonogenic growth in vitro: an independent biologic prognostic factor in ovarian carcinomaC Dittrich, E Dittrich, P Sevelda, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|June 1, 1986
Studies on the effects of betamethasone, L-carnitine, and betamethasone-L-carnitine combinations on the dipalmitoyl phosphatidylcholine content and phosphatidylcholine species composition in foetal rat lungsA Lohninger, H P Krieglsteiner, H Salzer, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1997
[Guidelines for surgical treatment of cervix carcinoma developed by the Standard Committee of the Austrian Society of Gynecology and Obstetrics. Austrian Society of Gynecology and Obstetrics]R Winter, H Concin, L Fuith, et al.
International Journal of Oncology|October 17, 1998
Prediction of toxicity but not of clinical course by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatinA Obermair, P Speiser, M Thoma, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1991
[Ferritin level in newborn infants after prepartal iron medication]M Barrada, N Pateisky, C Schatten, et al.
Wiener Klinische Wochenschrift|May 24, 1985
[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval]C C Zielinski, R Kuzmits, E Kubista, et al.
Pageof 18